Next Article in Journal
XXXVI Italian Congress of AIEOP
Previous Article in Journal
Pathological Basis of Symptoms and Crises in Sickle Cell Disorder: Implications for Counseling and Psychotherapy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 2
Issue 1
10.4081/hr.2010.e3
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

High Lymphoid Enhancer-Binding Factor-1 Expression Is Associated with Disease Progression and Poor Prognosis in Chronic Lymphocytic Leukemia

by
Felix Erdfelder
,
Magdalena Hertweck
,
Alexandra Filipovich
,
Sabrina Uhrmacher
and
Karl-Anton Kreuzer
*
Department I of Internal Medicine, University at Cologne, Kerpener Strasse 62, 50937 Cologne, Germany
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2010, 2(1), e3; https://doi.org/10.4081/hr.2010.e3
Submission received: 24 February 2010 / Revised: 19 April 2010 / Accepted: 22 April 2010 / Published: 6 May 2010

Abstract

We determined lymphoid enhancer-binding factor-1 (LEF1) mRNA expression in 112 chronic lymphocytic leukemia (CLL) samples and assessed correlations with the prognostic markers ZAP70 and CD38, Binet stages, the percentage of lymphocytes in the peripheral blood, and fibromodulin (FMOD) transcripts. The mean LEF1 relative expression ratios (RER) were 53.72 and 37.10 in ZAP70-positive and ZAP70-negative patients, respectively (p = 0.004). However, we did not observe a significant difference in LEF1 expression between CD38-positive and CD38-negative patients. Moreover, patients requiring treatment showed a mean LEF1 RER of 85.61 whereas patients in recently diagnosed Binet A stage had a mean of only 22.01 (p < 0.001). We also found significant correl­ations of LEF1 with the percentage of lymphocytes and FMOD expression. Our results suggest that high LEF1 expression is associated with poor prognosis and disease progression. Thus, LEF1 might be involved in the process of disease progression and possibly can serve as a molecular parameter for risk assessment and/or monitoring of CLL.
Keywords: lymphoid enhancer-binding factor-1 (LEF1); chronic lymphocytic leukemia (CLL); zeta-associated protein (ZAP70); CD38; fibromodulin lymphoid enhancer-binding factor-1 (LEF1); chronic lymphocytic leukemia (CLL); zeta-associated protein (ZAP70); CD38; fibromodulin

Share and Cite

MDPI and ACS Style

Erdfelder, F.; Hertweck, M.; Filipovich, A.; Uhrmacher, S.; Kreuzer, K.-A. High Lymphoid Enhancer-Binding Factor-1 Expression Is Associated with Disease Progression and Poor Prognosis in Chronic Lymphocytic Leukemia. Hematol. Rep. 2010, 2, e3. https://doi.org/10.4081/hr.2010.e3

AMA Style

Erdfelder F, Hertweck M, Filipovich A, Uhrmacher S, Kreuzer K-A. High Lymphoid Enhancer-Binding Factor-1 Expression Is Associated with Disease Progression and Poor Prognosis in Chronic Lymphocytic Leukemia. Hematology Reports. 2010; 2(1):e3. https://doi.org/10.4081/hr.2010.e3

Chicago/Turabian Style

Erdfelder, Felix, Magdalena Hertweck, Alexandra Filipovich, Sabrina Uhrmacher, and Karl-Anton Kreuzer. 2010. "High Lymphoid Enhancer-Binding Factor-1 Expression Is Associated with Disease Progression and Poor Prognosis in Chronic Lymphocytic Leukemia" Hematology Reports 2, no. 1: e3. https://doi.org/10.4081/hr.2010.e3

APA Style

Erdfelder, F., Hertweck, M., Filipovich, A., Uhrmacher, S., & Kreuzer, K. -A. (2010). High Lymphoid Enhancer-Binding Factor-1 Expression Is Associated with Disease Progression and Poor Prognosis in Chronic Lymphocytic Leukemia. Hematology Reports, 2(1), e3. https://doi.org/10.4081/hr.2010.e3

Article Metrics

Back to TopTop